Connect with us
In this final part of a four-part webinar recap, James Graham, Executive Director of Recce Pharmaceuticals (ASX:RCE) presented on the company’s latest announcements and updates, while answering...
In this part three of a four-part webinar recap, Darren Lui, President and Executive Director of Aptorum Group (NASDAQ/EURONEXT:APM) presented on the company’s latest announcements and updates,...
In this one of a four-part webinar recap, Mark Diamond, Managing Director & CEO of Antisense Therapeutics Limited (ASX:ANP) presented on the company’s latest announcements and...
StockPal is hosting its first Biotech & Healthcare webinar on 4 August for four ASX- and NASDAQ-listed health care companies. This webinar is co-organised with Rawson Lewis....
Yossi Keret is CEO of Nanorobotics, a disruptive startup in biotech, where he leads management, fundraising, financing, business development, strategic negotiations, and other company activities. In...
Watch Leslie Chong, Chief Executive Officer of Imugene Ltd (ASX:IMU) and Jared Sim, Editor-in-Chief and Co-Founder of StockPal in this engaging Q&A with the following questions:...
StockPal is hosting its first Biotech & Healthcare webinar for four ASX- and NASDAQ-listed health care companies. Each company is given 15 minutes to present via...
Dr. Graham Kelly is the Executive Chairman, CEO and Founder of Noxopharm (ASX:NOX), an Australian publicly-listed clinical stage drug development company. The clinical stage drug candidate...
Marc Voigt is the Chief Executive Officer of Immutep Limited (ASX:IMM), a biotechnology company working primarily in the field of cancer immunotherapy using the LAG3 immune...
Dr. Roger Aston is the Executive Chairman of PharmAust (ASX:PAA), a clinical-stage company developing targeted cancer therapeutics to address both human and animal healthcare. The company...